Jiannan Guo is the VP of Global R&D at NeoGenomics, specializing in clinical diagnostic NGS assays for precision oncology. With a PhD from the University of Birmingham, he leads the development of innovative cancer diagnostics, including liquid biopsy technologies for patient monitoring.
He is deeply committed to advancing cancer care, with a stated mission of growing his organizations impact to serve one million patients annually. His focus is on translating high-quality technical performance into scalable, end-user-focused diagnostic products that make a real-world difference.
Unique fact: He was the scientific lead for a novel circulating tumor DNA (ctDNA) assay that successfully received full FDA Premarket Approval (PMA) in December 2022.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.